Cannabis-Induced Acute Pancreatitis: A Systematic Review

被引:41
|
作者
Barkin, Jodie A. [1 ]
Nemeth, Zsuzsanna [2 ]
Saluja, Ashok K. [3 ]
Barkin, Jamie S. [1 ]
机构
[1] Univ Miami, Dept Med, Div Gastroenterol, Leonard M Miller Sch Med, 1120 NW 14th St,Clin Res Bldg,Suite 1116, Miami, FL 33136 USA
[2] Univ Miami, Dept Hlth Informat, Miami, FL USA
[3] Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL USA
关键词
cannabis; marijuana; acute pancreatitis; toxin; idiopathic; RARE CAUSE; MARIJUANA; DISORDERS;
D O I
10.1097/MPA.0000000000000873
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Cannabis is the most frequently consumed illicit drug in the world, with higher prevalence under the age of 35 years. Cannabis was first reported as a possible cause of acute pancreatitis (AP) in 2004. The aim of this systematic review is to examine cannabis use as an etiology of AP. Methods A search using PubMed/Medline, Embase, Scopus, and Cochrane was performed without language or year limitations to May 1, 2016. Search terms were Cannabis and Acute Pancreatitis with all permutations. The search yielded 239 results. Acute pancreatitis was defined by meeting 2 of 3 Revised Atlanta Classification criteria. Cannabis-induced AP was defined by preceding use of cannabis and exclusion of common causes of AP when reported. Sixteen papers met inclusion criteria dating from 2004 to 2016. Results There were 26 cases of cannabis-induced AP (23/26 men; 24/26 under the age of 35 y). Acute pancreatitis correlated with increased cannabis use in 18 patients. Recurrent AP related temporally to cannabis use was reported in 15 of 26. There are 13 reports of no further AP episodes after cannabis cessation. Conclusions Cannabis is a possible risk factor for AP and recurrent AP, occurring primarily in young patients under the age of 35 years. Toxicology screens should be considered in all patients with idiopathic AP.
引用
收藏
页码:1035 / 1038
页数:4
相关论文
共 50 条
  • [41] Cannabis-induced psychosis:: a cross-sectional comparison with acute schizophrenia
    Núñez, LA
    Gurpegui, M
    ACTA PSYCHIATRICA SCANDINAVICA, 2002, 105 (03) : 173 - 178
  • [42] Cannabis-Induced Depersonalization Disorder in Adolescence
    Huerlimann, Franziska
    Kupferschmid, Stephan
    Simon, Andor E.
    NEUROPSYCHOBIOLOGY, 2012, 65 (03) : 141 - 146
  • [43] Genetic moderation of cannabis-induced psychosis
    Henquet, Cecile
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 154S - 154S
  • [44] Role of blonanserin in cannabis-induced psychosis
    Pan, D.
    Mallik, A.
    Chakraborty, S.
    Sur, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S692 - S692
  • [45] Role of Blonanserin in Cannabis-induced Psychosis
    Pan, D.
    Mallick, A.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [46] Cannabis-induced Catatonia: A Case Study
    Herkert, Darby
    Majeske, Matthew
    JOURNAL OF PSYCHIATRIC PRACTICE, 2025, 31 (02) : 105 - 106
  • [47] Cannabis-induced cognitive and psychiatric disorders
    Dervaux, Alain
    Krebs, Marie-Odile
    Laqueille, Xavier
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (03): : 559 - 574
  • [48] Cannabis-induced psychosis: new entity?
    Makkos, Z.
    Fejes, L.
    Inczedy-Farkas, G.
    Kassai-Farkas, A.
    Lazary, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S450 - S451
  • [49] Cannabis-Induced Catatonia: A Case Series
    Mekala, Hema
    Malik, Zamaar
    Lone, Judith
    Shah, Kaushal
    Ishaq, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [50] Daily cannabis use may cause cannabis-induced hyperalgesia
    Zhang-James, Yanli
    Wyon, Evelyn
    Grapsas, Dennis
    Johnson, Brian
    AMERICAN JOURNAL ON ADDICTIONS, 2023, 32 (06): : 532 - 538